Cancer Family
Basal Cell Neoplasm
CI-CAN-00000072Explore in graph →
Non-malignant58 active trials4 approved drugs6 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000072Explore in graph →
Clinical trials
362 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06132191 | Expanded Access Use of Cemiplimab in Patients With Solid Tumors | approved for marketing | — | — | Regeneron PharmaceuticalsINDUSTRY | 0 | Nov 20, 2025 | clinicaltrials |
| NCT01160250 | A Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma | approved for marketing | — | — | Genentech, Inc.INDUSTRY | 1 | Aug 6, 2015 | clinicaltrials |
Data updated 22 days agoSource updated Nov 20, 2025source: clinicaltrials